Sanofi adds another AI alliance, this time for biologics with Baidu CEO’s startup
Sanofi has teamed up on artificial intelligence once again. This time, it’s partnering with BioMap, a startup chaired by the CEO of Baidu, a Chinese internet giant that previously inked its own AI-based mRNA deal with the French Big Pharma.
BioMap, which secured a $100 million Series A in 2021, could bag more than $1 billion in biobucks if the work gets into clinical testing and leads to marketed medicines. And while many AI-driven drug discovery shops go after small molecules, Sanofi is paying $10 million upfront to partner with the biologics-focused company.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.